Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Scheme Effective, Board Changes & AGM Resolutions

7 Sep 2023 07:32

RNS Number : 6406L
finnCap Group PLC
07 September 2023
 

FOR IMMEDIATE RELEASE

7 September 2023

finnCap Group plc ("finnCap" or the "Company")

 

SCHEME EFFECTIVE, CONFIRMATION OF BOARD CHANGES AND WITHDRAWAL OF AGM RESOLUTIONS

On 23 March 2023, the board of finnCap Group plc ("finnCap" or the "Company") and the board of Cenkos Securities plc ("Cenkos") announced that they had reached agreement on the terms and conditions of a recommended all-share merger between Cenkos and finnCap (the "Merger"), to be effected by means of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

finnCap is pleased to note the announcement released by Cenkos this morning that, following the delivery of a copy of the Court Order to the Registrar of Companies earlier today, the Scheme has now become effective and, accordingly, Cenkos is now a wholly-owned subsidiary of finnCap.

Board Changes and Withdrawal of Annual General Meeting ("AGM") Director Re-Election Resolutions

The Company confirms that the Board changes announced on 1 September 2023, which were conditional upon the Scheme becoming Effective, have now taken effect. Lisa Gordon, Julian Morse, Ben Procter and Jeremy Miller have been appointed as directors of the Company with effect from today, and, in accordance with the Company's Articles of Association, will stand for election by shareholders at the Company's 2023 AGM to be held at 10.00am on Friday 29 September 2023 at the Company's offices.

Barbara Firth, Andy Hogarth and Geoff Nash have resigned as directors of the Company with effect from today, and therefore resolutions 17, 18 and 19 (as set out in the Notice of AGM posted to shareholders on 6 September 2023) have been withdrawn.

Allotment and admission to trading of the 181,094,721 New finnCap Shares to be issued to Cenkos shareholders in consideration for the transfer of their Cenkos Shares is expected to take place on 8 September 2023. New shareholders in the Company as a result of the Merger will be entitled to vote on the resolutions to be proposed at the AGM. Such shareholders will receive a letter from the Company (expected to be posted on 8 September 2023) setting out details of the AGM, how to submit votes by proxy in advance of the AGM, and enclosing a Form of Proxy which can be used for that purpose.

Following admission to trading of the New finnCap Shares, the Company will have 362,189,565 ordinary shares of 1 penny each ("Ordinary Shares") in issue. The Company does not hold any shares in treasury and all of the Ordinary Shares have equal voting rights. The figure of 362,189,565 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

For information, please contact:

finnCap John Farrugia, Chief Executive Officer

Richard Snow, Chief Financial Officer

Henrik Persson, Strategic PLC Advisory

 

Tel: +44 (0)20 7220 0500

investor.relations@finncap.com

Grant Thornton (Nominated Adviser to finnCap)

Philip Secrett/Samantha Harrison/Samuel Littler

 

Tel: +44 (0)20 7383 5100

Oberon Capital (Joint Broker to finnCap)

Mike Seabrook

 

Tel: +44 (0)20 3179 5344

finnCap Ltd (Joint Broker to finnCap)

Tim Redfern

 

Tel: +44 (0)20 7220 0500

Hudson Sandler (PR Adviser to finnCap) Dan de Belder

Rebekah Chapman

 

Tel: +44 (0)7977 927142

Tel: +44 (0)7702 596674

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOADDGDCBBGDGXL
Date   Source Headline
19th Oct 20227:15 amRNSRule 2.9 Announcement
18th Oct 20222:58 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re finnCap plc
18th Oct 20227:00 amRNSResponse to offer speculation
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirectorate Change
15th Sep 202211:16 amRNSResult of AGM
15th Sep 20227:00 amRNSAGM Trading Update
1st Sep 20227:00 amRNSCEO Transition Completed
1st Sep 20227:00 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSDividend Declaration, Annual Report & AGM Notice
1st Aug 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSResults for year ended 31 March 2022
8th Jul 20227:00 amRNSAppointment of Executive Directors
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSProposed New CEO and appointment of new Directors
1st Jun 20227:00 amRNSBlock Admission Return and Total Voting Rights
16th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
28th Apr 20227:00 amRNSBuilding a leading advisory business
14th Apr 20227:23 amRNSFY22 Unaudited Revenue
1st Apr 20227:00 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTrading Update
1st Mar 20227:00 amRNSTotal Voting Rights
8th Feb 20229:18 amRNSDirector Dealing
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 202210:22 amRNSHolding(s) in Company
28th Jan 202210:21 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSOption Exercise, Dealing Amendment and TVR
25th Jan 20227:00 amRNSAppointment of Non-Executive Director
31st Dec 20217:00 amRNSTotal Voting Rights
9th Dec 20215:25 pmRNSHolding(s) in Company
8th Dec 20214:04 pmRNSCOVID Option Exercises and EBT Holdings in Company
1st Dec 20217:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 20217:00 amRNSInterim Results and Dividend
2nd Nov 20217:00 amRNSNotice of Interims and Investor Presentation
1st Nov 20217:00 amRNSTotal Voting Rights
19th Oct 202111:01 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSH1 22 Unaudited Revenues – strong growth on H1 21
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Sep 202111:21 amRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Trading Statement
15th Sep 20219:51 amRNSAGM Update
1st Sep 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSSecond Interim Dividend
7th Jul 202110:00 amRNSAnnual Report and Annual General Meeting Notice
6th Jul 20217:00 amRNSDirector Dealing, Option Exercise and TVR
1st Jul 20217:00 amRNSPreliminary results - year ended 31 March 2021
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.